Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.4%. By the end of trading, Covidien rose 55 cents (1%) to $55.62 on light volume. Throughout the day, 2.1 million shares of Covidien exchanged hands as compared to its average daily volume of three million shares. The stock ranged in a price between $54.86-$55.76 after having opened the day at $54.94 as compared to the previous trading day's close of $55.07. Other companies within the Health Services industry that increased today were:
), up 6.5%,
), up 6.3%,
), up 5.9%, and
), up 5.4%.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
Covidien Public Limited Company develops, manufactures, and sells healthcare products for use in clinical and home settings in the United States and internationally. Covidien has a market cap of $27.3 billion and is part of the
sector. The company has a P/E ratio of 14.1, below the average health services industry P/E ratio of 14.6 and below the S&P 500 P/E ratio of 17.7. Shares are up 22.4% year to date as of the close of trading on Thursday. Currently there are 16 analysts that rate Covidien a buy, one analyst rates it a sell, and one rates it a hold.
TheStreet Ratings rates Covidien as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, expanding profit margins, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Covidien Ratings Report.
On the negative front,
), down 12.7%,
), down 8.6%,
), down 8.2%, and
), down 5.4%, were all laggards within the health services industry with
) being today's health services industry laggard.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider
) while those bearish on the health services industry could consider
- Find other investment ideas from our top rated ETFs lists.